CARAFATE (Sucralfate) TABLET

ACTAVIS, INC

Revision date : 2014-08-30

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

232-679-6/9005-25-8

Name of the chemical

Starch

Concentration

54182-580

EC/CAS

272-939-6/68921-42-6

Name of the chemical

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)

Concentration

Proprietary

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

Proprietary

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

Proprietary

General Information

Revision date

2014-08-30

Product name

CARAFATE (Sucralfate) TABLET

Chemical name

For

1.2.1 Relevant identified uses

of the SUBSTANCE Human Pharmaceutical / Anti-Ulcer Agent

1.2.2. Uses advised against

Non-Pharmaceutical Use HOW SUPPLIED 1 g Light Pink Oblong Tablets NDC 58914-171-10 in bottles of 100

supplier name

U.S

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

Company Information

company name

ACTAVIS, INC

e-mail address of the competent person responsible for the Safety Data Sheet

SDS@Actavis.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is supplied as light pink oblong tablets

Health hazards

In the workplace, exposure to dusts from product via inhalation and skin contact may cause irritation Eye contact from dusts can cause mechanical irritation. Accidental ingestion may be harmful. In therapeutic use, the most common adverse effect reported has been constipation. Therapeutic use may cause adverse effects to the skin, central nervous and gastrointestinal systems. Serious hypersensitivity reactions have been reported, including anaphylactic reactions. Other adverse effects seen from therapeutic use are described in Section 11 (Toxicological information). Flammability Hazards: If heated to high temperatures for a prolonged period, the product may ignite. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including aluminum, carbon, sulfur and magnesium oxides). Reactivity Hazards: This product is not reactive.

Environmental hazards

Large quantities of this product released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations: Emergency responders should wear appropriate protection for the situation to which they respond.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.